CC
CELU icon

Centiva Capital’s Celularity CELU Stock Holding History

Centiva Capital’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,000
Closed -$1M – 652
2019
Q4 		$1M Hold
10,000
– – 0.05% 290
2019
Q3 		$999K Buy
+10,000
New +$981K 0.06% 218

Other funds holding CELU

BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Centiva Capital's CELU Position: Q1 2020 in Review

Centiva Capital sold out of Celularity (CELU) in Q1 2020, closing a stake of 10,000 shares — an estimated $1M sold.

Centiva Capital first reported a position in CELU in Q3 2019 and held it in 2 quarters. The position peaked at $1M in Q4 2019. 35 funds tracked by Wall St. Rank hold CELU as of Q1 2020.

  • Centiva Capital reported no remaining Celularity position as of Q1 2020 after selling out during the quarter.
  • Centiva Capital sold 10,000 Celularity shares in Q1 2020, an estimated $1M.
  • Centiva Capital first reported a position in Celularity in Q3 2019 and held it in 2 quarters.
  • Centiva Capital's Celularity position peaked at $1M in Q4 2019.
  • 35 funds tracked by Wall St. Rank held Celularity as of Q1 2020.

Based on Centiva Capital's 13F filing for Q1 2020, filed 15 May 2020.